Barry J. Simon - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of NantKwest Inc (NK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NantKwest Inc (NK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NantKwest Inc (NK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Barry J. Simon made no insider transaction in Cue Biopharma Inc (CUE). Other recent insider transactions involving Cue Biopharma Inc (CUE) include a net sale of 9,325 shares made by Peter A Kiener , a net purchase of 4,000 shares made by Anish Suri , and a net purchase of 3,000 shares made by Daniel R Passeri .

In summary, during the past 3 months, insiders sold 0 shares of Cue Biopharma Inc (CUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,325 shares of Cue Biopharma Inc (CUE) were sold and 7,000 shares were bought by its insiders, resulting in a net sale of 2,325 shares.

Cue Biopharma Inc (CUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Barry J. Simon made no insider transaction in Viracta Therapeutics Inc (VIRX). Other recent insider transactions involving Viracta Therapeutics Inc (VIRX) include a net sale of 21,403 shares made by Daniel R. Chevallard , a net sale of 4,272 shares made by Lisa Rojkjaer , and a net purchase of 100,000 shares made by Mark Rothera .

In summary, during the past 3 months, insiders sold 3,405 shares of Viracta Therapeutics Inc (VIRX) in total and bought 0 shares, with a net sale of 3,405 shares. During the past 18 months, 25,675 shares of Viracta Therapeutics Inc (VIRX) were sold and 100,000 shares were bought by its insiders, resulting in a net purchase of 74,325 shares.

Viracta Therapeutics Inc (VIRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Barry J. Simon made no insider transaction in ImmunityBio Inc (IBRX). Other recent insider transactions involving ImmunityBio Inc (IBRX) include a net purchase of 71,915 shares made by Michael D Blaszyk , a net purchase of 25,000 shares made by John Owen Brennan , and a net purchase of 7,000 shares made by Wesley Clark .

In summary, during the past 3 months, insiders sold 0 shares of ImmunityBio Inc (IBRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ImmunityBio Inc (IBRX) were sold and 103,915 shares were bought by its insiders, resulting in a net purchase of 103,915 shares.

ImmunityBio Inc (IBRX)'s detailed insider trading history can be found in Insider Trading Tracker table.